Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Eye Tech Care of France Reports $27 Million Funding from China

publication date: Jan 12, 2016
Eye Tech Care SA, a medical device maker located in Lyon, France, received a cross-border $27 million funding from China's Everpine Capital to support development of Eye Tech Care's non-invasive ultrasound treatment for glaucoma, particularly in China. EyeOP1®, an innovative medical device that uses Ultrasound Ciliary Plasty, treats uncontrolled glaucoma regardless of previous treatment. Eye Tech Care began the China registration process for EyeOPI in 2015. Everpine invests in companies that want to expand into China. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here